5401 - 5425 of 9148 Results
Title
Year
-
OPENTitle: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 10332End Page: 10332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms10332Best OA location URL: https://www.nature.com/articles/ncomms10332.pdfCitation Count: 97
- Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days2014OPENTitle: Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 DaysJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 5Start Page: e96675End Page: e96675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0096675Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096675&type=printableCitation Count: 222
- Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease2014OPENTitle: Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 5Start Page: e97032End Page: e97032Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0097032Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0097032&type=printableCitation Count: 76
-
OPENTitle: Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γAgonist against MPTPJournal Name: PPAR ResearchPublisher: WileyVol: 2013Issue #:Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2013/582809Best OA location URL: https://downloads.hindawi.com/journals/ppar/2013/582809.pdfCitation Count: 28
-
OPENTitle: O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's diseaseJournal Name: Nature ChemistryPublisher: Springer Science and Business Media LLCVol: 7Issue #: 11Start Page: 913End Page: 920Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nchem.2361Best OA location URL: http://doi.org/10.1038/nchem.2361Citation Count: 308
-
OPENTitle: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2Journal Name: Nature Chemical BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 203End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nchembio.538Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3287420Citation Count: 431
-
OPENTitle: Pitx3 is required for development of substantia nigra dopaminergic neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 100Issue #: 7Start Page: 4245End Page: 4250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0230529100Best OA location URL: http://doi.org/10.1073/pnas.0230529100Citation Count: 388
-
OPENTitle: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of PathologyJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 5Start Page: e94839End Page: e94839Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0094839Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094839&type=printableCitation Count: 390
-
OPENTitle: Neuroectodermal differentiation from mouse multipotent adult progenitor cellsJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 100Issue #: suppl_1Start Page: 11854End Page: 11860Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1834196100Best OA location URL: http://doi.org/10.1073/pnas.1834196100Citation Count: 348
-
OPENTitle: Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 101Issue #: 50Start Page: 17510End Page: 17515Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0405313101Best OA location URL: http://doi.org/10.1073/pnas.0405313101Citation Count: 319
- Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a2003OPENTitle: Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5aJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 100Issue #: 22Start Page: 12747End Page: 12752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1534900100Best OA location URL: http://doi.org/10.1073/pnas.1534900100Citation Count: 369
-
OPENTitle: Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 29Issue #: 1Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2007.08.008Best OA location URL: http://doi.org/10.1016/j.nbd.2007.08.008Citation Count: 74
-
OPENTitle: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 7314End Page: 7314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms8314Best OA location URL: https://www.nature.com/articles/ncomms8314.pdfCitation Count: 307
-
OPENTitle: Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonismJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 430End Page: 438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.02.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2605654Citation Count: 63
-
OPENTitle: Parkin-deficient mice are not a robust model of parkinsonismJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 102Issue #: 6Start Page: 2174End Page: 2179Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0409598102Best OA location URL: http://doi.org/10.1073/pnas.0409598102Citation Count: 471
-
OPENTitle: The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during agingJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 101Issue #: 26Start Page: 9843End Page: 9848Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0403495101Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/470762Citation Count: 502
- Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease2016RESTRICTEDTitle: Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 19End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.07.005Citation Count: 33
- Teaching program for the Unified Dyskinesia Rating Scale2009RESTRICTEDTitle: Teaching program for the Unified Dyskinesia Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 9Start Page: 1296End Page: 1298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22563Citation Count: 12
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 18
- Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics2005RESTRICTEDTitle: Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinicsJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 4Start Page: 519End Page: 23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20751Citation Count: 0
- Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 35
-
OPENTitle: The deterministic role of 5-mers in microRNA-gene targetingJournal Name: RNA BiologyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2018.1462652Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2018.1462652?needAccess=trueCitation Count: 16
-
OPENTitle: Precise disease heterogeneity and progression quantification in MSA and Parkinson’s disease using machine learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-026-45949-5Best OA location URL: https://www.nature.com/articles/s41598-026-45949-5_reference.pdfCitation Count: 0
- Therapeutic directions for Parkinson's disease2010RESTRICTEDTitle: Therapeutic directions for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S152End Page: 4Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22790Citation Count: 7
- Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative disease2018RESTRICTEDTitle: Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative diseaseJournal Name: Current Opinion in ToxicologyPublisher: Elsevier BVVol: 7Issue #:Start Page: 127End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cotox.2018.02.003Citation Count: 21